In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

From 1990 to 2023, there was a decrease in the number of births and, in general, total fertility rates (GFRs and TFRs), ...

From 1990 to 2023, there was a decrease in the number of births, general fertility rates, and total fertility rates in the United States.

Researchers have found in a new study that patients receiving a combination of metformin and SGLT2 inhibitors experienced a ...

Cognitively impaired patients with CKD more frequently experience a host of health problems and are at higher risk for death. Cognitive impairment in patients with chronic kidney disease (CKD) is ...

France: A recent case published in BMC Nephrology highlights the possible role of tranexamic acid (TXA) in precipitating ...

Presented positive updated data from ASPEN-06 Phase 2 trial demonstrating evorpacept generates strong response and durable clinical benefit in ...

Adding cabozantinib to first-line treatment with nivolumab and ipilimumab improved PFS — but not OS — in patients with RCC.

Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) TD Cowen 45th Annual Health Care Conference Transcript March 3, 2025 3:10 PM ET David Altshuler - Executive Vice President, Global Research and CSO ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for ...